Exagen Inc
General ticker "XGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $86.4M
Exagen Inc follows the US Stock Market performance with the rate: 42.0%.
Estimated limits based on current volatility of 9.2%: low 4.81$, high 5.64$
Factors to consider:
- Current price 55.4% above estimated high
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.22$, 3.19$]
- 2024-12-30 to 2025-12-30 estimated range: [1.68$, 3.98$]
Financial Metrics affecting the XGN estimates:
- Negative: Non-GAAP EPS, $ of -1.34 <= 0.10
- Negative: Operating profit margin, % of -30.29 <= 1.03
- Negative: Operating cash flow per share per price, % of -32.83 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term XGN quotes
Long-term XGN plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $48.30MM | $45.56MM | $52.55MM |
Operating Expenses | $72.37MM | $91.61MM | $75.39MM |
Operating Income | $-24.07MM | $-46.05MM | $-22.84MM |
Non-Operating Income | $-2.61MM | $-1.62MM | $-0.82MM |
Interest Expense | $2.62MM | $2.45MM | $2.33MM |
R&D Expense | $7.24MM | $9.88MM | $4.87MM |
Income(Loss) | $-26.68MM | $-47.67MM | $-23.66MM |
Taxes | $0.17MM | $-0.28MM | $0.03MM |
Profit(Loss) | $-26.85MM | $-47.39MM | $-23.69MM |
Stockholders Equity | $84.94MM | $42.46MM | $22.69MM |
Inventory | $1.09MM | $1.79MM | $2.87MM |
Assets | $123.44MM | $86.22MM | $56.94MM |
Operating Cash Flow | $-20.27MM | $-32.14MM | $-14.46MM |
Capital expenditure | $2.37MM | $4.32MM | $0.83MM |
Investing Cash Flow | $-2.42MM | $-4.32MM | $-0.80MM |
Financing Cash Flow | $64.68MM | $-0.49MM | $-10.63MM |
Earnings Per Share* | $-1.68 | $-2.77 | $-1.34 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.